Cytori Therapeutics Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$1.48 |
Market Cap |
$5.2 M |
Shares Outstanding |
22.16 M |
Public Float |
12.66 M |
Address |
3020 Callan Road San Diego California 92121 United States |
Employees | - |
Website | http://www.cytori.com |
Updated | 07/08/2019 |
Cytori Therapeutics, Inc. is a late stage cell therapy company which engages in the development of autologous cell therapies from adipose tissue, using its proprietary technology, to treat a variety of medical conditions. It offers the Cytori Nanomedicine, Cytori Cell Therapy, and other clinical trials. The company was founded by Ralph E. |